Dr. Priyanka Singh | Nanobiotechnology Awards | Most Cited Paper Award

Posted on by ScienceFather

Dr. Priyanka Singh | Nanobiotechnology Awards | Most Cited Paper Award

Dr. Priyanka Singh , Denmark Technical University , Denmark

Dr. Priyanka Singh is a Senior Researcher at the Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark. With over seven years of post-doctoral experience, she specializes in green nanoscience and medical biology, focusing on innovative drug development for cancer and infections. Dr. Singh holds a Ph.D. in Nanoscience from Kyung Hee University and has secured substantial external funding for her pioneering research in nanomaterials. She is also committed to mentoring Ph.D. students and fostering interdisciplinary collaborations to advance cell biology and translate research into impactful outcomes.

Professional Profile:

Google Scholar

Education:

Dr. Priyanka Singh earned her Ph.D. in Nanoscience from Kyung Hee University, South Korea, in 2016, where she designed nanoparticles and drug conjugates/nanoformulations to enhance the pharmacokinetics of poorly water-soluble drugs for cancer and infectious cells. She holds a Diploma in Transformational Leadership Programme-Leading Women from CBS, Denmark, completed in November 2020. Dr. Singh has acquired several certifications from the University of Wisconsin–Madison, USA, including physiological characterization, solubilization, and solid form screening for drugs (2022), biologics (2021), drug development processes and CMC aspects (2021), and preclinical and phase 1 oral drug formulations (2021). Additionally, she completed a Teaching Lab course at DTU in January 2022, focused on university-level teaching and learning. Her academic background also includes a Master’s in Microbiology from CSJMU, India (2008-2010), and a Bachelor’s in Microbiology from Kachchh University, India (2005-2008).

Work Experience:

Dr. Priyanka Singh is a Senior Researcher at the Center for Biosustainability, Technical University of Denmark, since December 2023. She leads studies on developing nanomaterials for anticancer and antimicrobial drugs, publishing in high-impact journals, and supervises Ph.D. students in hands-on development of these materials. She is also leading a project on “graphene-based solutions for marine biofilm inhibition” and employs advanced techniques like Flow cytometry, SEM, TEM, and Incucyte for characterizing nanomaterials in various disease models. From January 2021 to November 2023, as a Researcher at the same center, she led a team advancing nanomaterials in medical applications, focusing on biologics formation and characterization, investigating their impact on cancer cells, and enhancing their therapeutic potential.

Publication Top  Notes:

 

 

Prof. Dr. Vlasta Bonačić-Koutecky | Nanobiotechnology Award | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Vlasta Bonačić-Koutecky | Nanobiotechnology Award | Best Researcher Award

Prof. Dr. Vlasta Bonačić-Koutecky  , Humbolt University, ICAST University of Split , Germany

Vlasta Bonačić-Koutecký is a distinguished Professor at the Department of Chemistry, Humboldt University, Berlin. Since 2010, she has been instrumental in founding the Interdisciplinary Center for Advanced Science and Technology (ICAST) at the University of Split, Croatia, and assumed leadership of the Center of Excellence STIM in 2014. Her groundbreaking work in nanoscience focuses on metal nanoclusters, highlighting their unique structural, optical, and reactivity properties that blend molecular-like characteristics with metallic traits. This innovative approach has expanded the boundaries of traditional nanoscience, integrating small metal nanoclusters into materials science. Her research spans nanocatalysis for renewable energy, nano-optics, and nano-biosensing for medical diagnostics

Professional Profile:

Scopus

Orcid

Education:

Vlasta Bonačić-Koutecký earned her PhD in Chemistry from Humboldt University in Berlin. Her doctoral studies laid the foundation for her distinguished career in nanoscience, focusing particularly on the unique properties of metal nanoclusters. This academic journey at Humboldt University equipped her with the expertise to explore the structural, optical, and reactivity characteristics of these nanoclusters, which blend molecular-like features with metallic attributes. Her research has significantly advanced the field of nanoscience, particularly in integrating small metal nanoclusters into materials science for applications in nanocatalysis for renewable energy, nano-optics, and nano-biosensing for medical diagnostics

Work Experience:

Professor Vlasta Bonačić-Koutecký holds a prominent position at the Department of Chemistry, Humboldt University, Berlin, where she contributes significantly to the field of chemistry. Since 2010, she has also been instrumental in founding and directing the Interdisciplinary Center for Advanced Science and Technology (ICAST) at the University of Split in Croatia. Under her leadership, ICAST has fostered interdisciplinary research at the intersection of various scientific disciplines. In addition to her role at ICAST, Professor Bonačić-Koutecký has served as the head of the Center of Excellence STIM at the University of Split since 2014. This center focuses on achieving excellence in research and innovation, further solidifying her reputation as a leader in advancing scientific knowledge and interdisciplinary collaboration.

Research Focus:

Professor Vlasta Bonačić-Koutecký is a leading figure in nanoscience, specializing in metal nanoclusters. Her research focuses on unraveling the structural, optical, and reactivity properties of these nanoclusters, which exhibit a unique blend of molecular-like characteristics and metallic behavior. She has pioneered their application in diverse fields such as nanocatalysis for renewable energy, leveraging their catalytic efficiency, nano-optics for advanced optical materials, and nano-biosensing for precise medical diagnostics. Through her innovative approach, Professor Bonačić-Koutecký has expanded the frontiers of nanoscience, demonstrating the transformative potential of metal nanoclusters across interdisciplinary research and technological applications.

Publication Top Notes:

1. Ligand Impact on Reactive Oxygen Species Generation of Au10 and Au25 Nanoclusters upon One- and Two-Photon Excitation

  • Journal: Communications Chemistry
  • Publication Year: 2023
  • Volume: 6
  • Citations: 5

2. Excitation-Dependent Fluorescence with Excitation-Selective Circularly Polarized Luminescence from Hierarchically Organized Atomic Nanoclusters

  • Journal: ACS Nano
  • Publication Year: 2023
  • Volume: 17
  • Citations: 4

3. Model Systems for Dye-Sensitized Solar Cells: Cyanidin-Silver Nanocluster Hybrids at TiO2 Support

  • Journal: RSC Advances
  • Publication Year: 2023
  • Citations: 2

4. Engineering Liganded Gold Nanoclusters as Efficient Theranostic Agents for Cancer Applications

  • Journal: ChemBioChem
  • Publication Year: 2023
  • Citations: 6

5. Stability and Properties of New-Generation Metal and Metal-Oxide Clusters Down to Subnanometer Scale

  • Journal: Physical Chemistry Chemical Physics
  • Publication Year: 2023 (Article in Press)

 

 

Mr. Thiago Jordão S Lemos | Nanobiotechnology Awards | NanoHealth Innovator Prize

Posted on by ScienceFather

Mr. Thiago Jordão S Lemos | Nanobiotechnology Awards | NanoHealth Innovator Prize

Mr. Thiago Jordão S Lemos , Instituto Butantan , Brazil

Thiago Jordão da Silva Lemos is a biomedical researcher currently affiliated with the Butantan Institute in São Paulo, Brazil. He earned his degree in Biomedicine from Universidade Paulista (UNIP) and has extensive experience in research and development, particularly in immunology and animal health. He completed a postgraduate program at the Butantan Institute, focusing on microbiology, where he investigated the immune response induced by an oral vaccine against E. coli serogroups O26 and O111. Lemos has also held roles as a nursing technician and assistant and participated in a short-term internship at the Biophysics Institute of the Federal University of Rio de Janeiro (UFRJ). His research interests include vaccine development and infectious diseases, and he is actively involved in evaluating immune responses to pathogens in order to develop effective vaccines.

Professional Profile:

Orcid

 🎓Education:

Thiago Jordão da Silva Lemos earned his degree in Biomedicine from Universidade Paulista (UNIP), Brazil, with a thesis titled “Frequency of Bovine Viral Diarrhea in the State of São Paulo,” under the guidance of Ediviges Maristela Pituco. He further pursued postgraduate studies at the Butantan Institute, focusing on microbiology, where he researched the immune response induced by an oral vaccine against E. coli serogroups O26 and O111. Additionally, Lemos completed a short-term internship at the Biophysics Institute of the Federal University of Rio de Janeiro (UFRJ)

 🏢Work Experience:

Lemos is currently affiliated with the Butantan Institute in São Paulo, Brazil, where he works on evaluating immune responses to pathogens to develop effective vaccines. He has held roles as a nursing technician and assistant and has been a member of a research team investigating the immune response induced by an oral vaccine against E. coli serogroups O26 and O111. His professional experience encompasses research and development in immunology and animal health, with a focus on vaccine development and infectious diseases.

Publication Top Notes:

  • O26 Polysaccharides as Key Players in Enteropathogenic E. coli Immune Evasion and Vaccine Development
    • Journal: International Journal of Molecular Sciences
    • Publication Date: 2024-03-01
  • Characterization of O26 Enteropathogenic E. coli and Its Implication for Vaccine Development
    • Publication Date: 2023-12-19
  • The potential of Loxosceles gaucho spider venom to regulate Pseudomonas aeruginosa mechanisms of virulence
    • Journal: Toxicon
    • Publication Date: 2018
  • Potential influence of bacterial biofilm formation on scalp folliculitis therapy